Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Weekly high-dose 5-fluorouracil as 24-h infusion and folinic acid (AIO) plus irinotecan as second- and third-line treatment in patients with colorectal cancer pre-treated with AIO plus oxaliplatin.
Stickel F, Jüngert B, Brueckl V, Schirner I, Brueckl WM, Männlein G, Hegewald J, Mühldorfer S, Bittorf B, Hohenberger W, Hahn EG, Wein A. Stickel F, et al. Among authors: brueckl wm, brueckl v. Anticancer Drugs. 2003 Oct;14(9):745-9. doi: 10.1097/00001813-200310000-00010. Anticancer Drugs. 2003. PMID: 14551509
Impact of surgery on survival in palliative patients with metastatic colorectal cancer after first line treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and folinic acid.
Wein A, Riedel C, Köckerling F, Martus P, Baum U, Brueckl WM, Reck T, Ott R, Hänsler J, Bernatik T, Becker D, Schneider T, Hohenberger W, Hahn EG. Wein A, et al. Among authors: brueckl wm. Ann Oncol. 2001 Dec;12(12):1721-7. doi: 10.1023/a:1013521430755. Ann Oncol. 2001. PMID: 11843250 Free article. Clinical Trial.
Alterations in the tissue inhibitor of metalloproteinase-3 (TIMP-3) are found frequently in human colorectal tumours displaying either microsatellite stability (MSS) or instability (MSI).
Brueckl WM, Grombach J, Wein A, Ruckert S, Porzner M, Dietmaier W, Rümmele P, Croner RS, Boxberger F, Kirchner T, Hohenberger W, Hahn EG, Jung A. Brueckl WM, et al. Cancer Lett. 2005 Jun 1;223(1):137-42. doi: 10.1016/j.canlet.2004.09.037. Epub 2004 Nov 2. Cancer Lett. 2005. PMID: 15890246
[Chronic gout. Case report of a severe course of disease].
Boxberger F, Harsch IA, Brueckl WM, Hautmann M, Baum U, Hahn EG, Wein A. Boxberger F, et al. Among authors: brueckl wm. Med Klin (Munich). 2003 Nov 15;98(11):646-7. doi: 10.1007/s00063-003-1310-9. Med Klin (Munich). 2003. PMID: 14631540 German. No abstract available.
54 results